Methylation status and long‐fragment cell‐free DNA are prognostic biomarkers for gastric cancer.

MLA

Ko, Kazuhide, et al. “Methylation Status and Long‐fragment Cell‐free DNA Are Prognostic Biomarkers for Gastric Cancer.” Cancer Medicine, vol. 10, no. 6, Mar. 2021, pp. 2003–12. EBSCOhost, https://doi.org/10.1002/cam4.3755.

APA

Ko, K., Kananazawa, Y., Yamada, T., Kakinuma, D., Matsuno, K., Ando, F., Kuriyama, S., Matsuda, A., & Yoshida, H. (2021). Methylation status and long‐fragment cell‐free DNA are prognostic biomarkers for gastric cancer. Cancer Medicine, 10(6), 2003–2012. https://doi.org/10.1002/cam4.3755

Chicago

Ko, Kazuhide, Yoshikazu Kananazawa, Takeshi Yamada, Daisuke Kakinuma, Kunihiko Matsuno, Fumihiko Ando, Sho Kuriyama, Akihisa Matsuda, and Hiroshi Yoshida. 2021. “Methylation Status and Long‐fragment Cell‐free DNA Are Prognostic Biomarkers for Gastric Cancer.” Cancer Medicine 10 (6): 2003–12. doi:10.1002/cam4.3755.